Replies to post #35685 on RespireRx Pharmaceuticals Inc (fka RSPI)

[jerrydylan]

I didn't say it was or wasn't. I said it be a "sign"....I also said it was an awful licensing/partnering environment. I am looking for something more in the way of news and I am hopeful for that. These things can move in chunks and volume is the key typically.

[atheroprevent]

Looks like the 143 posters on this board have maxed out their holdings in Corx. Agree, the ampakine universe is small. The shrinking R+D force will just have to barter their expertise for drug. :)

[Market_Fest4]

Any positive response is immediately removed with the realization that current management is still just limping along with no proven ability to advance the platform in a paralel way. No prospects for improved funding, etc.

As long as this failed model of the last 15 years is the status quo, I will not buy another share. I want to see the CORX compounds in the hands of a true BP that values them as a top-3 priority. Anything less, and CORX goes the way of other pink sheets with much "potential" like PTN.
MF4